✦ LIBER ✦

Clinical outcomes after implantation of small diameter (= 2.5 mm) sirolimus- versus paclitaxel-eluting stents

✍ Scribed by Laurent Bonello; Ashesh N. Buch; Axel De Labriolle; Probal Roy; Daniel H. Steinberg; Tina L. Pinto Slottow; Kimberley Kaneshige; Rebecca Torguson; William O. Suddath; Lowell F. Satler; Kenneth M. Kent; Augusto D. Pichard; Ron Waksman

Book ID: 116547863
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 102 KB
Volume: 144
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2008.12.145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcomes after implantation of

Clinical outcomes after implantation of 2.5-mm-diameter sirolimus vs. 2.5-mm-diameter paclitaxel-eluting stents in unselected patients with coronary artery disease

✍ A.N. Buch; S. Singh; P. Roy; A. Javaid; D.H. Steinberg; T.L. Pinto Slottow; T. O 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Clinical outcomes after implantation of

Clinical outcomes after implantation of sirolimus- vs paclitaxel-eluting stents in unselected patients with small coronary arteries (2.5 mm)

✍ L Bonello; AN Buch; A De Labriolle; P Roy; DH Steinberg; TL Pinto Slottow; Z Xue 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Zotarolimus Eluting Stent use in small c

Zotarolimus Eluting Stent use in small coronary vessels (≤2.5 mm) results in similar 12-month clinical outcomes compared to Sirolimus and Paclitaxel eluting stents

✍ R. Gurvitch; W. Wilson; M. Watts; J. Lefkovits; R.J. Warren; R. Iyer; A. Brennan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Five-year clinical outcomes of sirolimus

Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients

✍ K. Anette Birkmeier; Adnan Kastrati; Robert A. Byrne; Heidrun Holle; Stefanie Sc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract Objectives and Background: First generation drug‐eluting stents have shown differential efficacy in high‐risk patient subsets at one year. It is unclear whether these differences endure over the medium‐ to long‐term. We compared the five‐year clinical efficacy and safety of sirolimus‐el

CLINICAL OUTCOMES ASSOCIATED WITH OFF-LA

CLINICAL OUTCOMES ASSOCIATED WITH OFF-LABEL USE OF SIROLIMUS- VERSUS PACLITAXEL-ELUTING STENTS

✍ Yamamoto, Myong Hwa; Ochiai, Masahiko; Ashida, Kazuhiro; Yakushiji, Tadayuki; Ya 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

FIVE-YEAR CLINICAL OUTCOME AFTER IMPLANT

FIVE-YEAR CLINICAL OUTCOME AFTER IMPLANTATION OF SIROLIMUS-ELUTING STENTS VERSUS PACLITAXEL-ELUTING STENTS IN UNSELECTED PATIENTS WITH CORONARY ARTERY DISEASE: KOMATE DES REGISTRY

✍ Ko, Young-Guk; Kim, Jung-Sun; Choi, Donghoon; Hong, Myeong-Ki; Jnag, Yangsoo; Mi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Clinical outcomes after implantation of small diameter (=&#xa0;2.5 mm) sirolimus- versus paclitaxel-eluting stents

Clinical outcomes after implantation of small diameter (= 2.5 mm) sirolimus- versus paclitaxel-eluting stents